Final extension for AsiaPharm takeover set for May 22

MBK Partners stands firm on its takeover offer which, as of April 30, had been accepted by 77.19% of AsiaPharmÆs shareholders. Templeton remains opposed to the deal.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition